S Endres Selected Research

S Endres Research Topics

Disease

7	Neoplasms (Cancer) 12/2014 - 12/2000
3	Pancreatic Neoplasms (Pancreatic Cancer) 12/2014 - 09/2001
3	Colitis 10/2001 - 01/2000
2	Inflammation (Inflammations) 10/2001 - 03/2000
1	Hip Osteoarthritis (Coxarthrosis) 11/2012
1	Glucose Intolerance 06/2010
1	Diabetes Mellitus 06/2010
1	Hyperaldosteronism (Conn Syndrome) 06/2010
1	Arthritis (Polyarthritis) 09/2005
1	Intervertebral Disc Displacement (Herniated Disc) 08/2005
1	Eczema 07/2005
1	Bacterial Infections (Bacterial Infection) 07/2005
1	Job Syndrome (Hyper-IgE Syndrome) 07/2005
1	Reinfection 07/2005
1	Pancreatitis 02/2003
1	Crohn Disease (Crohn's Disease) 10/2001
1	Asthma (Bronchial Asthma) 10/2001
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2001
1	Yellow Fever 09/2001
1	Autoimmune Diseases (Autoimmune Disease) 09/2001
1	Virus Diseases (Viral Diseases) 07/2001
1	Shock 06/2001
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2001
1	Hyperplasia 01/2001
1	Lymphoma (Lymphomas) 01/2001
1	Hypoxia (Hypoxemia) 03/2000
1	Weight Loss (Weight Reduction) 01/2000
1	Hemorrhage 01/2000

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 12/2014 - 03/2000
4	AntigensIBA 12/2014 - 01/2001
4	CPG-oligonucleotideIBA 12/2001 - 12/2000
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2005 - 12/2000
3	Dextran SulfateIBA 10/2001 - 01/2000
2	LigandsIBA 12/2014 - 07/2005
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 09/2001 - 03/2000
2	Drinking WaterIBA 01/2001 - 01/2000
1	CalreticulinIBA 12/2014
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2014
1	InflammasomesIBA 12/2014
1	StaurosporineIBA 12/2014
1	HMGB1 Protein (HMG1)IBA 12/2014
1	PotassiumIBA 06/2010
1	AldosteroneIBA 06/2010
1	Antihypertensive Agents (Antihypertensives)IBA 06/2010
1	Gemcitabine FDA Link 09/2007
1	sphingosine kinaseIBA 01/2006
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2006
1	Peptidoglycan (Murein)IBA 07/2005
1	Immunoglobulin E (IgE)IBA 07/2005
1	IonomycinIBA 07/2005
1	Interleukin-2 (IL2)IBA 07/2005
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2005
1	ZymosanIBA 07/2005
1	Pharmaceutical PreparationsIBA 02/2003
1	InterferonsIBA 10/2001
1	InterleukinsIBA 10/2001
1	Interleukin-18 (Interleukin 18)IBA 10/2001
1	Phosphodiesterase 4 InhibitorsIBA 10/2001
1	Neoplasm Antigens (Tumor Antigens)IBA 09/2001
1	VaccinesIBA 09/2001
1	Cancer VaccinesIBA 09/2001
1	Antisense OligonucleotidesIBA 06/2001
1	Proteins (Proteins, Gene)FDA Link 06/2001
1	OligodeoxyribonucleotidesIBA 01/2001
1	CpG ODN 2006IBA 01/2001
1	GP 1-515IBA 01/2001
1	Adenosine KinaseIBA 01/2001
1	GuanosineIBA 12/2000
1	Phosphates (Orthophosphate)IBA 12/2000
1	DNA (Deoxyribonucleic Acid)IBA 12/2000
1	CytidineIBA 12/2000
1	Interleukin-6 (Interleukin 6)IBA 03/2000
1	Phosphodiesterase InhibitorsIBA 01/2000
1	ImmunosorbentsIBA 01/2000
1	EnzymesIBA 01/2000
1	RolipramIBA 01/2000

Therapy/Procedure

4	Immunotherapy 12/2014 - 01/2001
3	Therapeutics 08/2005 - 01/2001
1	Hip Replacement Arthroplasty (Total Hip Replacement) 11/2012
1	Drug Therapy (Chemotherapy) 09/2007
1	Knee Replacement Arthroplasty (Total Knee Replacement) 09/2005
1	Arthroplasty 09/2005